Rapdog
2021-11-04
Great
[得意]
U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":846928749,"tweetId":"846928749","gmtCreate":1636040839449,"gmtModify":1636040839563,"author":{"id":3570877693225065,"idStr":"3570877693225065","authorId":3570877693225065,"authorIdStr":"3570877693225065","name":"Rapdog","avatar":"https://static.tigerbbs.com/539ed1f3dfd2b609e8dafdf2714b309c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great <span>[得意] </span></p></body></html>","htmlText":"<html><head></head><body><p>Great <span>[得意] </span></p></body></html>","text":"Great [得意]","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/846928749","repostId":1167697278,"repostType":2,"repost":{"id":"1167697278","kind":"news","pubTimestamp":1636025569,"share":"https://www.laohu8.com/m/news/1167697278?lang=&edition=full","pubTime":"2021-11-04 19:32","market":"us","language":"en","title":"U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697278","media":"Bloomberg","summary":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s ","content":"<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.</p>\n<p>The U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.</p>\n<p>Merck shares rose 2% in premarket U.S. trading.</p>\n<p><img src=\"https://static.tigerbbs.com/228503f62c7823fd2b8b78316babd5e6\" tg-width=\"847\" tg-height=\"622\" width=\"100%\" height=\"auto\"></p>\n<p>Boris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.</p>\n<p>Coronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.</p>\n<p>Based on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.K. Drug Regulator Is First to Approve Merck’s Covid-19 Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:32 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-04/u-k-drug-regulator-is-first-to-approve-merck-s-covid-19-pill?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167697278","content_text":"Britain became the first country to approve Merck & Co’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective.\nThe U.K.’s Medicines and Healthcare products Regulatory Agency authorized the drug, molnupiravir, for use in people with mild to moderate Covid and at least one risk factor for developing severe illness, the regulator said in a statement Thursday.\nMerck shares rose 2% in premarket U.S. trading.\n\nBoris Johnson’s government plans to focus on antiviral treatments at the same time as rolling out boosters to bolster immunity levels as winter approaches. The U.K. has already announced deals to secure two new Covid treatments: 480,000 courses of Merck’s pill and 250,000 courses of Pfizer Inc.’s PF 07321332/ritonavir.\nCoronavirus infections in England reached their highest level yet in October, based on a large study published Thursday. While hospitalizations and deaths remained low, the React-1 study led by Imperial College London recorded the highest prevalence of cases since the research began in May 2020. Covid infections among study participants increased to 1.72%, or one in 58 people, more than double the level in the previous month’s report.\nBased on the clinical trial data, Merck’s pill is most effective when taken during the early stages of infection, the regulator said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":854,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":11,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/846928749"}
精彩评论